Joint Ventures And CollaborationsHEALWELL formed a 50/50 joint venture with WELL to advance clinical research initiatives, which could enhance focus and resources in this area.
Revenue GrowthHEALWELL AI reported 2Q25 results with revenue of C$40.5M, up 645% year-over-year, and adjusted EBITDA of C$1.9M, the company's first positive quarter.
Strategic RefocusingThe company has successfully shed its complex, low-margin, and distracting conglomerate identity by divesting its physical clinics, its small-to-medium business-focused AI tool, and de-consolidating its clinical research businesses into a joint venture.